MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gastrointestinal problemsm(also see autonomic dysfunction)"

  • 2025 International Congress

    DPPX Autoimmune Encephalitis Presenting with Chorea

    T. Le, S. Pradeep (Houston, USA)

    Objective: To report a case of a rare autoimmune disorder associated with dipeptidyl-peptidase-like protein- 6 (DPPX) antibodies, highlighting its classical features, diagnostic challenges, and therapeutic…
  • 2025 International Congress

    Impact of Gastrointestinal Dysfunction Symptoms on Psychomotor Recovery Following 8-Week Aerobic Interval Training in Parkinson’s Disease – Preliminary Results

    K. Lorek, K. Markowska, A. Bereza, E. Koziorowska, S. Budrewicz, P. Nowakowski, S. Chomiak (Wroclaw, Poland)

    Objective: To investigate the impact of gastrointestinal dysfunction symptoms (GIDS) on psychomotor recovery following 8-week aerobic interval training (AIT) in Parkinson's disease (PD). Background: GIDS…
  • 2025 International Congress

    NIH funds Gut-Brain Parkinson’s Disease Consortium

    C. Goetz, L. Becker, A. Bharucha, E. Chang, A. Keshavarzian, B. Kuo, K. Newby, K. Poston, L. Sanders, R. Savica, A. Sharma, A. Videnovic, L. Wruck, T. Xie (Chicago, USA)

    Objective: Describe the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) multicenter (UO1) Consortium on PD Gut-Brain Communication. Background: A 2024 Notice of Funding…
  • 2025 International Congress

    Turkish Validity and Reliability Study of the Gastrointestinal Dysfunction Scale for Parkinson’s Disease

    S. Irmak, H. Omercikoglu, D. Gunal (İstanbul, Turkey)

    Objective: The aim of this study is to make a Turkish adaptation of the "Gastrointestinal Dysfunction Scale for PD (GIDS-PD)"and detect gastrointestinal symptoms at an…
  • 2025 International Congress

    Helicobacter Pylori Infection, Peptic Ulcer, Gastritis and Risk of Parkinson´s Disease: a Nationwide Matched Cohort Study

    S. Licaj, A. Ploner, A. Szwajda, S. Hägg, F. Fang, J. Ludvigsson, K. Wirdefeldt (Solna, Sweden)

    Objective: To examine the potential link between H. pylori infection, gastritis, peptic ulcer and Parkinson’s Disease (PD) risk. Background: Gastrointestinal disorders are frequent among PD…
  • 2024 International Congress

    Beyond constipation: gastrointestinal phenomena in Parkinson’s disease

    MA. Silveira, H. Dourado, G. Procópio, M. Sampaio, IJ. Oliveira, L. Almeida, G. Valença (Salvador, Brazil)

    Objective: To describe the prevalence of gastrointestinal manifestations in patients with Parkinson's disease in a Brazilian movement disorders outpatient clinic and evaluate their associated factors…
  • 2024 International Congress

    Non-Motor Symptoms and Comorbidities in a Cohort of Puerto Rican Parkinson’s Disease: Do They Affect Severity and Progression?

    C. Serrano, K. Palermo, M. Morales, V. Wojna (San Juan, Puerto Rico)

    Objective: To describe for the first time the frequency of non-motor symptoms (NMS) and comorbidities in a group of idiopathic Parkinson disease (IPD) patients at…
  • 2024 International Congress

    Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease

    K. Tosefsky, Y. Wang, A. Kuan, V. Ngo, C. Agu, D. Liang, L. Liu, O. Geiger, S. Keymanesh, M. Sacheli, E. Gerson, S. Cresswell (Vancouver, Canada)

    Objective: ​​​To assess the feasibility of combining Mediterranean and ketogenic dietary principles in persons with Parkinson’s disease (PwP). Background: Dietary interventions have been proposed as…
  • 2024 International Congress

    Reduced intestinal inflammation and increased levels of short-chain fatty acids thanks to an active lifestyle in Parkinson’s disease.

    NES. Chtioui, CHR. Duval, DAV. St-Pierre (Montreal, Canada)

    Objective: This study aimed to determine whether people with Parkinson’s disease (PD) with an active lifestyle had increased production of certain microbial metabolites such as…
  • 2024 International Congress

    A Randomized, Double-Blind, Placebo-Controlled Trial of a Multi-Strain Probiotic for Anxiety in Parkinson’s Disease

    J. Lam, P. Uzelman, J. Zhu, D. Meng, F. Pio, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the effect of a multi-strain probiotic on anxiety in patients with Parkinson’s disease (PD). Background: There is a lack of dedicated randomized…
  • 1
  • 2
  • 3
  • …
  • 11
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley